Literature DB >> 2417938

Epitope diversity of angiotensin II analysed with monoclonal antibodies.

C Picard, P Ronco, P Moullier, J Yao, B Baudouin, M Geniteau Legendre, P Verroust.   

Abstract

The antigenic heterogeneity of angiotensin II (AII) was studied with monoclonal antibodies. Twelve antibodies were produced and characterized. Association constants for AII varied from 1.2 X 10(8) to 1.1 X 10(10) M-1. The fine specificity of the Mab was studied by immunoenzymoassay using solid-phase AII. Using AII analogues in binding inhibition experiments, three groups of specificity could be characterized: (1) five antibodies reacted only with peptides in which phenylalanine is the carboxy terminal aminoacid; for two of these antibodies, tyrosine4 is closely associated with the binding site, since iodine labelling suppresses reactivity; (2) two antibodies also required phenylalanine in position 8, but, in addition, reacted with AI, a decapeptide in which phenylalanine is not terminal; (3) five antibodies reacted with analogues in which phenylalanine had been substituted for another amino acid. In addition, studies in which binding of a biotinylated Mab to solid-phase AII was analysed in the presence of various unlabelled Mab suggest further antigenic heterogeneity of AII.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417938      PMCID: PMC1453881     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  A proposed conformation of isoleucyl-5-angiotensin II.

Authors:  R R SMEBY; K ARAKAWA; F M BUMPUS; M M MARSH
Journal:  Biochim Biophys Acta       Date:  1962-04-23

3.  Angiotensin receptors in vascular tissue.

Authors:  M A Devynck; P Meyer
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

Review 4.  Pharmacology of angiotensin.

Authors:  D Regoli; W K Park; F Rioux
Journal:  Pharmacol Rev       Date:  1974-06       Impact factor: 25.468

5.  Evidence for renal glomerular receptors for angiotensin II.

Authors:  J D Sraer; J Sraer; R Ardaillou; O Mimoune
Journal:  Kidney Int       Date:  1974-10       Impact factor: 10.612

6.  Selectivity of angiotensin II antisera.

Authors:  J Nussberger; G R Matsueda; R Re; E Haber
Journal:  J Immunol Methods       Date:  1983       Impact factor: 2.303

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  A monoclonal antibody to brush border and passive Heymann nephritis.

Authors:  P Ronco; L Allegri; C Melcion; E Pirotsky; M D Appay; J Bariety; F Pontillon; P Verroust
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

9.  Mapping epitopes on the insulin molecule using monoclonal antibodies.

Authors:  J A Schroer; T Bender; R J Feldmann; K J Kim
Journal:  Eur J Immunol       Date:  1983-09       Impact factor: 5.532

10.  A simplified radioimmunoassay for physiologically active angiotensin peptides [(1-8) octa- and (2-8) heptapeptides].

Authors:  J Nussberger; R Re; G R Matsueda; E Haber
Journal:  Horm Metab Res       Date:  1984-11       Impact factor: 2.936

View more
  2 in total

1.  COVID-19-A theory of autoimmunity to ACE-2.

Authors:  Philip McMillan; Bruce D Uhal
Journal:  MOJ Immunol       Date:  2020-05-27

2.  Presence of renin, angiotensinogen, angiotensin II in the lamb anterior pituitary gland: immunocytochemical study after cryoultramicrotomy.

Authors:  S Kettani; V Beldent; M C Rousselet; P Ronco; P Verroust; J P Saint-Andre
Journal:  Histochemistry       Date:  1991
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.